Exelixis, Inc.

Exelixis, Inc.

Exelixis, Inc.

Overview
Date Founded

1994

Headquarters

210 EAST GRAND AVENUE, SOUTH SAN FRANCISCO, CA, 94080

Type of Company

Public

Employees (Worldwide)

773

Industries

Biotechnology
Hospitals & Patient Services
Pharmaceuticals

Company Description

Exelixis is a biopharmaceutical company committed to developing and commercializing small molecule therapies for the treatment of cancer. In advancing our first product, COMETRIQ, from discovery to market, we have established an effective and integrated infrastructure that encompasses the entire biopharmaceutical development continuum. We are committed to excellence in all aspects of our work and are dedicated to improving the care and outcome of cancer patients.

Contact Data
Trying to get in touch with decision makers at Exelixis, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

President & Chief Executive Officer

Chief Financial Officer & Executive Vice President

Executive Vice President & General Counsel

Executive Vice President, Scientific Strategy & Chief Scientific Officer

President, Product Development & Medical Affairs & Chief Medical Officer

Executive Vice President-Human Resources

Executive Vice President, Public Affairs & Investor Relations

Executive Vice President, Commercial

Executive Vice President, Business Operations

Board of Directors

Co-Founder at Exelixis, Inc.

President & Executive Director at Foundation for the National Institutes of Health, Inc.

Provost at Harvard University

Vice Chairman at Inform Diagnostics, Inc.

Former Executive Vice President & Chief Financial Officer at VWR International LLC

Founder at Biotechnology Innovation Organization

Former Founding Partner at DCF Capital LLC

Co-Founder at The American Academy of Anti-Aging Medicine, Inc.

President & Chief Executive Officer at E-Scape Bio, Inc.

President & Chief Executive Officer at Exelixis, Inc.

Paths to Exelixis, Inc.
Potential Connections via
Relationship Science
You
Exelixis, Inc.
Owners & Shareholders
Details Hidden

Renaissance Technologies LLC is an investment management company dedicated to producing superior returns for its clients and employees by adhering to mathematical and statistical methods.

Details Hidden

MCM utilizes a bottom-up stock picking approach which is based on fundamental research and analysis. Their investment philosophy is based on the potential to add value through active management. The firm invests across market caps and believes that different companies need to be measured by different metrics. The investment managers conduct an extensive program of company visits complemented by external research from a network of consultants.

Details Hidden

FCM seeks investments across asset classes and around the world through a process of bottom-up fundamental research and analysis emphasizing capital preservation. Their investment strategies include Credit Investments, Long/Short Equity, Merger Arbitrage, Risk Arbitrage, Real Estate Investments and Direct Investments. Investment ideas compete for capital based on in-depth, critical assessment of specific risks and rewards. Risk is monitored and managed through rigorous and thorough analysis of each investment and, at the portfolio level, through risk management analytics and overlay and tail-risk hedging.

Recent Transactions
Details Hidden

Exelixis, Inc. issued USD Common Stock

Details Hidden

Exelixis, Inc. issued USD Common Stock

Details Hidden

Exelixis, Inc. issued USD Common Stock

Insider Transactions
Details Hidden
Details Hidden
Details Hidden
Transaction Advisors
Underwriter

Advised onExelixis, Inc. issued USD Common Stock

Underwriter

Advised onExelixis, Inc. issued USD Common Stock

Legal Advisor

Advised onExelixis, Inc. issued USD Common Stock

Managing Director Head of Equity Capital Markets, Initial Public Offerings

Advised onExelixis, Inc. issued USD Common Stock

Managing Director, ECM

Advised onExelixis, Inc. issued USD Common Stock

Corporate Officer

Advised onExelixis, Inc. issued USD Common Stock

Advisors & Consultants
Legal Advisor

Partner, Palo Alto at Cooley LLP

Legal Advisor

Partner, San Francisco at Cooley LLP

Legal Advisor

Partner at Jones Day

Clients

CVS Health Corp. engages in the provision of health care services. It operates through the following segments: Pharmacy Services, Retail or Long Term Care, Health Care Benefits, and Corporate. The Pharmacy Services segment offers pharmacy benefit management solutions. The Retail or Long Term Care segment includes selling of prescription drugs and assortment of general merchandise. The Health Care Benefits segment offers traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioural health, medical management capabilities. The Corporate segment involves in providing management and administrative services. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

AmerisourceBergen Corp. engages provision of pharmaceutical products and business solutions that improve access to care. It operates through the Pharmaceutical Distribution Services and Other segments. The Pharmaceutical Distribution Services segment distributes a comprehensive offering of brand-name, specialty brand-name & generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies & equipment, outsourced compounded sterile preparations, and related services to a wide variety of healthcare providers, including acute care hospitals and health systems, independent & chain retail pharmacies, mail order pharmacies, medical clinics, long-term care & alternate site pharmacies, and other customers. The Other segment focuses on global commercialization services and animal health and includes ABCS, World Courier, and MWI. The company is headquartered in Chesterbrook, PA.

UnitedHealth Group is a leading health care company, serving more than 75 million people worldwide. Our family of companies touches nearly every aspect of health care, helping people live healthier lives. We apply our capabilities broadly across health care in markets worldwide, providing health care management, consulting and specialty services globally. And we have the scale and resources necessary to take on some of the most important challenges in global health care. (www.unitedhealthgroup.com/global) As a leader in the health benefits and services industry, our six businesses — UnitedHealthcare Employer & Individual, UnitedHealthcare Medicare & Retirement, UnitedHealthcare Community & State, OptumHealth, OptumInsight, and OptumRx — offer exceptional service, broad capabilities and enduring value in creating a modern health care system. Our products and services empower individuals, expand consumer choice and strengthen patient-provider relationships across the health care spectrum

Key Stats and Financials As of 2020
Market Capitalization
$6.84B
Total Enterprise Value
$4.56B
Earnings Per Share
$1.02
Revenue
$988M
Total Equity
$1.88B
Net Profit
$112M
EBITDAMargin
12.56%
Total Debt
$52.1M
EBITDA
$124M
Enterprise Value / Sales
5.29x
TEVNet Income
46.77x
Debt TEV
0.01x
Enterprise Value EBITDAOperating
41.73x
Three Year Compounded Annual Growth Rate Of Revenue
29.69%
Non-Profit Donations & Grants
Investments
Details Hidden

Gentris Corp. provides applied clinical phamacogenomic services. The company was founded on March 2001 and is headquartered in Morrisville, NC.

Investors
Details Hidden

Distinguished Professor of Chemistry & Biochemistry at The University of Colorado

Suppliers
Ceres, Inc. (California) Agriculture & Mills | Arden Hills, MN

Ceres, Inc. develops and markets seeds and traits to produce crops for feed, forages, sugar and other markets. It uses a combination of plant breeding, biotechnology and bioinformatics to develop seed products and biotechnology traits. The company was founded by Walter De Logi, Richard William Hamilton and Robert B. Goldberg in 1996 and is headquartered in Thousand Oaks, CA.

Ligand Pharmaceuticals, Inc. Medical Support Services | La Jolla, CA

Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA.

Invenra, Inc. Medical Support Services | Madison, WI

Invenra, Inc. develops technology platform for biological drugs. It is a pre-clinical stage bio-pharmaceutical company focused on next-generation therapeutic human antibodies and antibody derivatives. The company was founded by Roland Greene and Emile F. Nuwaysir on July 24, 2014 and is headquartered Madison, WI.

Competitors
Merck & Co., Inc. Pharmaceuticals - Kenilworth, NJ

Merck & Co., Inc. , d.b.a. Merck Sharp & Dohme, MSD outside the United States and Canada, is an American pharmaceutical company and is one of the largest pharmaceutical companies in the world.

Johnson & Johnson Pharmaceuticals - New Brunswick, New Jersey

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas such as immunology, infectious diseases ad vaccines, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular, diabetes care, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

Amgen, Inc. Biotechnology - Thousand Oaks, CA

Amgen, Inc. is a biotechnology medicines company, which discovers, develops, manufactures and markets medicines for grievous illnesses. The company focuses on human therapeutics and concentrates on innovating novel medicines based on advances in cellular and molecular biology. It markets recombinant protein therapeutics in supportive cancer care, nephrology and inflammation. The company's products include Neulasta, a pegylated protein, based on the Filgrastim molecule and NEUPOGEN, a recombinant-methionyl human granulocyte colony stimulating factor both of which selectively stimulate the production of neutrophils; Enbrel, an inhibitor of tumor necrosis factor, a substance that plays a role in the body's response to inflammatory diseases; Sensipar/Mimpara, a small molecule calcimimetic that lowers serum calcium levels; Vectibix, a monoclonal antibody that binds specifically to the epidermal growth factor receptor; and Nplate, a thrombopoietin receptor agonist that mimics endogenous TPO, the primary driver of platelet production. Amgen was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Exelixis, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Exelixis, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Exelixis, Inc..